Empowering mental health professionals with peer-reviewed psychiatric research and insights
Page 88
More JCP Articles
Original Research
Psychotic Features in Patients With MDD
January 15, 2019
Psychotic features within major depressive disorder (MDD) are associated with poor treatment outcome. This article explores whether sociodemographic and clinical characteristics of and pharmacologic treatments received by patients with…
Original Research
Long-Term Remission With Cariprazine in Patients With Schizophrenia
January 8, 2019
When treating patients with schizophrenia, achieving stable, long-term remission is an important step toward the goal of functional recovery. This study evaluated the effect of cariprazine on several measures…
Original Research
Cost-Effectiveness of “Next-Step” Depression Treatment Strategies
December 18, 2018
Aripiprazole is commonly prescribed as a next-step pharmacotherapy for treatment-resistant depression, but its cost-effectiveness as an adjunct to antidepressants is unknown. Read this article to learn how the cost-effectiveness…
Original Research
Valbenazine for Tardive Dyskinesia: Results From the KINECT 3 Study
December 18, 2018
Could valbenazine help your patients who experience antipsychotic-induced abnormal movements? This follow-up analysis of a phase 3 study provides further insights into the efficacy of valbenazine for tardive dyskinesia…
Clinical and Practical Psychopharmacology
How to Read a Research Paper: An Exercise in Critical Thinking
December 11, 2018
Tamsulosin, used to treat benign prostatic hyperplasia, was associated in a recent study with an increase in the risk of incident dementia. In this installment of his column, Dr…
